PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2024-07-08

Date Title Company
08-Jul-2024 Richland Aesthetics, Newport Beach's Luxury Med Spa AccessWire
08-Jul-2024 Core One Enters into Loan Agreement with Right Season Investments AccessWire
08-Jul-2024 Spur provides update on FLT201 and planned Phase III clinical trial Syncona Limited
08-Jul-2024 Scailyte Strengthens Its Leadership Newswire
08-Jul-2024 Scailyte Strengthens Its Leadership AccessWire
08-Jul-2024 APEIRON Biologics to be Acquired by Ligand Pharmaceuticals for USD 100 Million APEIRON Biologics AG
08-Jul-2024 Au Pair USA Celebrates 35 Years of Connecting International Au Pairs with U.S. Host Families AccessWire
08-Jul-2024 Just - Evotec Biologics Expands Tech Partnership for Biosimilars with Sandoz AccessWire
08-Jul-2024 Just – Evotec Biologics expands tech partnership for biosimilars with Sandoz Evotec SE
08-Jul-2024 Pharmaceutical Analytical Testing Outsourcing Market to Hit USD 15.8 Billion by 2032 Global Market Insights, Inc.
08-Jul-2024 TuHURA Biosciences Enters into Exclusivity and Right of First Offer Agreement for Kineta, Inc.’s KVA12123 Novel anti-VISTA Checkpoint Inhibitor AccessWire
08-Jul-2024 TheraNatal Complete Recognized as Top Prenatal Vitamin by The Bump AccessWire
08-Jul-2024 DEFENCE RECEIVES NO OBJECTION LETTER FROM HEALTH CANADA FOR PHASE I TRIAL OF ITS ACCUM-002 (ACCUTOX) AS AN ANTI-CANCER MOLECULE IN PATIENTS WITH MELANOMA Defence Therapeutics Inc.
08-Jul-2024 Spexis AG: PARI Pharma GmbH announces termination of ColiFin® license to EnBiotix, Inc. Spexis AG